America Great Health (AAGH)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 15, 2026, 4:00 PM EST
Market Cap21.15K -100.0%
Revenue (ttm)391.74K +32.9%
Net Income-719.12K
EPS-0.00
Shares Out21.15B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume528,865
Open0.0001
Previous Close0.0001
Day's Range0.0001 - 0.0001
52-Week Range0.000001 - 0.0180
Beta6.40
RSI40.42
Earnings DateNov 28, 2025

About America Great Health

America Great Health operates as a biotechnology company in the United States. It focuses on the research and development of protein and peptide small molecular drugs; and manufacture and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and regenerative medicine and nutritional dietary supplements. The company was formerly known as Crown Marketing and changed its name to America Great Health in March 2017. America Great Health is based in Alhambra, California. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Mike Wang
Employees 5
Stock Exchange OTCMKTS
Ticker Symbol AAGH
Full Company Profile

Financial Performance

In fiscal year 2025, America Great Health's revenue was $391,743, an increase of 32.94% compared to the previous year's $294,670. Losses were -$719,119, -41.08% less than in 2024.

Financial Statements